W. Stille
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 28
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 12
- Virology top 5%
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 36
- Drug-Induced Adverse Reactions 9
-
- Neutropenia and Cancer Infections 12
-
- Bacterial Identification and Susceptibility Testing 10
-
- Pharmaceutical studies and practices 9
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Co-authors
- P. M. ShahE. B. HelmG. Just‐NüblingHR BrodtS StaszewskiClaus SimonAngelika BöhmeD. Hoelzer
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
W. Stille
143 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 149
- Molecular Medicine 190
- Infectious Diseases 501
- Virology 119
- Pharmacology 396
- Applied Microbiology and Biotechnology 44
Countries citing papers authored by W. Stille
This map shows the geographic impact of W. Stille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Stille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Stille more than expected).
Fields of papers citing papers by W. Stille
This network shows the impact of papers produced by W. Stille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Stille. The network helps show where W. Stille may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Stille, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2004 | 4 | |
| 5 | 2001 | 1 | |
| 6 | 2000 | 2 | |
| 7 | 1998 | 10 | |
| 8 | 1997 | 1 | |
| 9 | 1996 | 42 | |
| 10 | 1996 | 32 | |
| 11 | 1993 | 12 | |
| 12 | 1991 | 56 | |
| 13 | 1989 | 5 | |
| 14 | 1988 | 33 | |
| 15 | 1987 | 6 | |
| 16 | 1987 | 28 | |
| 17 | Suramin treatment for AIDS [letter] | 1985 | 1 |
| 18 | [Therapy of meningitis (author's transl)]. | 1976 | 2 |
| 19 | Antibiotika-Therapie in Klinik und Praxis | 1970 | 80 |
| 20 | [TICK-BORNE ENCEPHALITIS IN WEST GERMANY]. | 1965 | 4 |
About W. Stille
W. Stille is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Infectious Diseases, having authored 161 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (36 papers), Antibiotic Resistance in Bacteria (28 papers), Neutropenia and Cancer Infections (12 papers), Antifungal resistance and susceptibility (12 papers), Bacterial Identification and Susceptibility Testing (10 papers), Pharmaceutical studies and practices (9 papers), Drug-Induced Adverse Reactions (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). The work is most often cited by research in Molecular Medicine (190 citations), Infectious Diseases (501 citations), Virology (119 citations), Pharmacology (396 citations) and Applied Microbiology and Biotechnology (44 citations). W. Stille has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include P. M. Shah, E. B. Helm, G. Just‐Nübling, HR Brodt, S Staszewski, Claus Simon, Angelika Böhme, D. Hoelzer, A. H. Staib and S. Harder. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Infection, Drugs, AIDS and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.